Leon E. Rosenberg
Président chez Talon Therapeutics, Inc.
Postes actifs de Leon E. Rosenberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Président | 01/02/2004 | - |
Independent Dir/Board Member | 01/02/2004 | - | |
Princeton University | Corporate Officer/Principal | 01/09/1997 | - |
Yale University | Corporate Officer/Principal | 27/04/2011 | - |
Historique de carrière de Leon E. Rosenberg
Anciens postes connus de Leon E. Rosenberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
Email Real Estate.com, Inc. | Directeur/Membre du Conseil | - | 13/10/2004 |
BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | 01/01/1997 | 01/03/1998 |
Bristol-Myers Squibb Pharmaceutical Research Institute | President | 01/09/1991 | 01/01/1997 |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Directeur/Membre du Conseil | 01/01/2000 | - |
Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM. | Directeur/Membre du Conseil | 01/01/1997 | - |
KARO PHARMA AB (PUBL) | Président | - | - |
Formation de Leon E. Rosenberg
University of Wisconsin | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Suède | 2 |
Suisse | 2 |
Opérationnelle
Director/Board Member | 3 |
Chairman | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Consumer Services | 4 |
Health Technology | 4 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
KARO PHARMA AB (PUBL) | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Entreprise privées | 5 |
---|---|
Email Real Estate.com, Inc. | Finance |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Lovelace Respiratory Research Institute
Lovelace Respiratory Research Institute Miscellaneous Commercial ServicesCommercial Services Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM. | Commercial Services |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Commercial Services |
Bristol-Myers Squibb Pharmaceutical Research Institute |
- Bourse
- Insiders
- Leon E. Rosenberg
- Expérience